Select your country

Africa
Asia
Europe
Latin America
North America
Oceania

Open Target Sourcing

Do you have interesting data on a new biological concept or target in the area of oncology, immuno-oncology or autoimmunity? You can be part of a new drug development success story!


Have you discovered a potential new therapeutic target?

New insights into pathophysiological processes are the basis for all innovative drug development programs. We invite you to collaborate with us and to investigate new biological phenomena which may result in drugs for future breakthrough therapies. 

How does it work?

Please register and send us a non-confidential information package, which is under your control and ownership (meaning, use references if relevant). We will get back to you immediately to discuss possible next steps such as a confidentiality agreement or a potential collaboration contract.

Confidentiality & IP protection

  • We will not obtain any rights during the entire evaluation process.
  • Based on your initial submission, we will inform you whether we are interested in moving forward in a formalized, confidential way. 

The path forward

  • We evaluate your submitted information and potentially discuss with you the option of further exploring your findings with us through a drug discovery and research collaboration.
  • We might invite you to visit our campus in Darmstadt, Germany to present your research topic and to have an exchange with scientists at Merck KGaA, Darmstadt, Germany.
  • We might also offer you support to achieve IP protection of your results.

We are eager to get in touch with you to discuss and explore the potential of your findings for drug discovery. We look forward to hearing from you! 

Redirect

You have accessed emdgroup.com, but for users from your part of the world, we originally designed the following web presence merckgroup.com

Let's go